Study of the Clinical Effect of External Oblique Muscle Intercostal Muscle Plane Block in Abdominal Surgery

NCT06684210 | Completed DMC

• 1 other identifier: WCX123456
• Study Type: interventional
• Target: 60
• Locations: 1 country
• Sites: 1

Brief Summary

This study intends to apply external oblique intercostal muscle plane block in thoracoabdominal resection, and to explore its effect on perioperative analgesia and rehabilitation quality in patients undergoing thoracoabdominal surgery.

Conditions

Nerve Block; Pain

Outcome Measures

Primary Outcomes (1)

• Patient's postoperative pain score

  Using the VIsual Analogue Scale,patients were guided to indicate the corresponding pain score according to their own pain situation, and the score ranged from 0 to 10. To evaluate the degree of postoperative pain, a score of 0 indicates no pain at all, a score of 2 indicates mild pain, and a score of 10 indicates the most severe pain, with higher scores indicating more severe pain

  Extubation for 30minutes, 6 hours after surgery, 24 hours after surgery, and 48 hours after surgery

Secondary Outcomes (3)

• Changes in blood pressure

  Perioperative period

• Changes in heart rate

  Perioperative period

• Extent of action of external oblique intercostal muscle plane block

  Ten minutes after the nerve block

Study Arms (2)

External oblique intercostal plane block.

EXPERIMENTAL

Given 0.5% ropivacaine intercostal nerve block, 2.0ug/kg sufentanil + tropisetron 5mg intravenous analgesia.

Procedure: Intercostal plane block of the external oblique muscle

Patient controlled in travenousanalgesia.

NO INTERVENTION

Given intravenous analgesia with 2.0ug/kg sufentanil + tropisetron 5 mg.

Interventions

Intercostal plane block of the external oblique muscle PROCEDURE

Under ultrasound guidance, a single dose of 0.25% ropivacaine 20ml was given for bilateral intercostal muscle plane block of external oblique muscles

External oblique intercostal plane block.

Eligibility Criteria

• Age: 18 Years - 60 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64)

You may qualify if:

• ASA Physical Status Classification of I-II Aged 18-60 years old ; Will be scheduled to undergo elective LC

You may not qualify if:

• Coagulation disorders, Liver/kidney disease, Abdominal surgery history, Infection in the block application area, Chronic opioid use.

Sponsors & Collaborators

• The First Hospital of Qinhuangdao: lead

Study Sites (1)

The first hospital of Qinhuangdao

Qinhuangdao, Hebei, 066000, China

Location

MeSH Terms

Conditions

Pain

Condition Hierarchy (Ancestors)

Neurologic Manifestations; Signs and Symptoms; Pathological Conditions, Signs and Symptoms

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: SINGLE
• Who Masked: PARTICIPANT
• Purpose: PREVENTION
• Intervention Model: PARALLEL
• Sponsor Type: OTHER GOV
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: October 17, 2024
• First Posted: November 12, 2024
• Study Start: March 1, 2023
• Primary Completion: January 1, 2024
• Study Completion: February 1, 2024
• Last Updated: November 12, 2024

Record last verified: 2024-11

Locations

CN (1)